Mouse and cat cells were each examined for the mode of restriction of endogenous xenotropic oncornavirus. Murine xenotropic helper virus (MuX) and its pseudo-type of Moloney murine sarcoma virus (MSV(MuX)) were grown in cat cells to high titre. MuX alone did not replicate in any mouse cell tested including normal or transformed outbred Swiss 3T3 cells or SC-1 cells, but did grow in a variety of other mammalian cells. MSV(MuX) was not able to achieve that intracellular state from which it could be rescued by mouse leukaemia virus (MuLV) in any mouse cell tested with the exception of SC-1 cells. Detection of MSV(MuX) foci with appropriate helper virus was as sensitive in SC-1 cells as in the cells of several other species. Sequential passage of MSV(MuX) virus complex in SC-1 cells resulted in a loss of infectious sarcoma and helper viruses, but transformed, MSV rescuable cells were retained.
If cat embryo cells were infected with either the feline endogenous xenotropic virus (FeX) or its MSV pseudotype (MSV(FeX)), two analogous states of restriction were observed. FeX alone did not replicate in cat cells as measured by release of progeny virus or by FeX group-specific antigen induction. Cat cells could be susceptible or insusceptible to the entry of MSV(FeX) as measured by MSV rescue with appropriate ecotropic feline leukaemia virus. The sensitivity of detection of MSV(FeX) foci in some cat cells in the presence of feline ecotropic virus was comparable to that exhibited by cells of other mammalian species. A single strain of cat cells underwent a change in its restrictive capacity for MSV(FeX) on prolonged passage. Late passage cat cells became very insusceptible to MSV(FeX) but not to other pseudotypes of MSV. Infectious FeX or its group-specific antigens were not detected in the insusceptible cells. The major glycoprotein of FeX did appear as a surface antigen of the insusceptible cells. It is apparent that two levels of cellular restriction can be distinguished in each of two mammalian cell systems by the susceptibility to penetration of MSV coated with endogenous xenotropic oncornavirus.
AaronsonS. A.,
StephensonJ. R.1973; Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proceedings of the National Academy of Sciences of the United States of America 70:2055–2058
BassinR. H.,
TuttleN.,
FischingerP. J.1970; Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. International Journal of Cancer 6:95–107
CrandellR. A.,
FabricantC. G.,
Nelson-ReesW. A.1973; Development, characterization and viral susceptibility of a feline (Fells catus) renal cell line (CRFK). In Vitro 9:176–185
FischingerP. J.,
O’connorT. E.1970; Productive infection and morphologic alteration of human cells by a modified sarcoma virus. Journal of the National Cancer Institute 44:429–438
FischingerP. J.,
PeeblesP. T.,
NomuraS.,
HaapalaD. K.1973; Isolation of an RD-114-like oncornavirus from a cat cell line. Journal of Virology 11:978–985
GildenR. V.,
OroszlanS.1972; Group-specific antigens of RNA tumor viruses as markers for subinfectious expression of the RNA virus genome. Proceedings of the National Academy of Sciences of the United States of America 69:1021–1025
GisselbrechtS.,
BassinR. H.,
GerwinB. I.,
ReinA.1974; Dual susceptibility of a 3T3 mouse cell line to infection by N- and B-tropic murine leukemia virus: apparent lack of expression of the FV-ι gene. International Journal of Cancer 14:106–113
GrantJ. P.,
BignerD. D.,
FischingerP. J.,
BolognesiD. P.1974; Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proceeding of the National Academy of Sciences of the United States of America 71:5037–5041
GreenR. W.,
BolognesiD. P.,
SchäferW.,
PisterL.,
HunsmannG.,
De NoronhaF.1973; Polypeptides, of mammalian on cornaviruses. I. Isolation and serological analysis of polypeptides from murine and feline C-type viruses. Virology 56:565–579
HartleyJ. W.,
RoweW. P.,
HuebnerR. J.1970; Host range restrictions of murine leukemia viruses in mouse embryo cell culture. Journal of Virology 5:221–225
HendersonI. C.,
LieberM. M.,
TodaroG. J.1974; Mink cell line MviLU(CCL64): focus formation and the generation of ‘nonproducer’ transformed cell lines with murine and feline sarcoma viruses. Virology 60:282–287
HuangA. S.,
BesmerP.,
ChuL.,
BaltimoreD.1973; Growth of pseudotypes of vesicular stomatis virus, with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. Journal of Virology. 12:659–662
HunsmannG.,
MoennigV.,
PisterL.,
SeifertE.,
SchäferW.1974; Properties of mouse leukemia viruses. VIII. The major viral glycoprotein of Friend leukemia virus. Seroimmunological, interfering and hemag-glutinating capacities. Virology 62:307–318
LivingstonD. M.,
TodaroG. J.1973; Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C viruses. Virology 53:142–151
LowyD. R.,
ChattopadhyayS. K.,
TeichN. M.,
RoweW. P.,
LevineA. S.1974; ARK murine leukemia virus genome: frequency of sequences in DNA of high-, low- and non-virus-yielding mouse strains. Proceedings of the National Academy of Sciences of the United States of America 71:3555–3559
MoennigV.,
FrankH.,
HunsmannG.,
SchneiderI.,
SchäferW.1974; Properties of mouse leukemia viruses. VII. The major viral glycoprotein of Friend leukemia virus. Isolation and physicochemical properties. Virology 61:100–111
NomuraS.,
BassinR. H.,
FischingerP. J.1972a; Replication of radiation-induced murine leukemia virus in normal and transformed mouse cells. Journal of Virology 9:494–502
NomuraS.,
DunnK. J.,
MatternC. F. T.,
HartleyJ. W.,
FischingerP. J.1974; Revertants of mouse cells transformed by murine sarcoma virus. Flat variants without a rescuable sarcoma genome from a clone of BALB/3T3 transformed by Kirsten MSV. Journal of General Virology 25:207–218
NomuraS.,
FischingerP. J.,
MatternC. F. T.,
PeeblesP. T.,
BassinR. H.,
FriedmanG. P.1972b; Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology 50:51–64
SchäferW.,
HunsmannG.,
MoennigV.,
De NoronhaF.,
BolognesiD. P.,
GreenR. W.,
HuperG.1975; Polypeptides of mammalian oncornaviruses. II. Characterization of a murine leukemia virus polypeptide (p15) bearing interspecies reactivity. Virology (in the press)
SchäferW.,
FischingerP. J.,
LangeJ.,
PisterL.1972; Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology 47:197–209
StrandM.,
AugustI. T.1974; Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. Journal of Virology 13:171–180
StrandM.,
LillyF.,
AugustJ. T.1974; Host control of endogenous murine leukemia virus gene expression: concentrations of viral proteins in high and low leukemia mouse strains. Proceedings of the National Academy of Sciences of the United States of America 71:3682–3686
TodaroG. J.,
ArnsteinP.,
ParksW. P.,
LennetteE. H.,
HuebnerR. J.1973a; A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proceedings of the National Academy of Sciences of the United States of America 70:859–862
TronickS. R.,
StephensonJ. R.,
AaronsonS. A.1973; Immunological characterization of a low molecular weight polypeptide of murine leukemia virus. Virology 54:199–206